Overview

To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
A phase Ⅰ study to evaluate the pharmacokinetic interactions and safety between fimasartan and rosuvastatin in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Collaborators:
Kyungpook National University
Kyungpook National University Hospital
Treatments:
Rosuvastatin Calcium